Suven Pharmaceuticals Limited has informed the Exchange about General Updates
COHANCE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Suven Pharmaceuticals Limited has officially changed its name to Cohance Lifesciences Limited, following approval from the Ministry of Corporate Affairs on May 7, 2025. Both NSE and BSE have approved the change, and from May 19, 2025, the stock will trade under the new name. The NSE trading symbol will change from SUVENPHAR to COHANCE, while the BSE scrip code remains 543064. This is a rebranding update and does not involve any change in the company's business, share structure, or listing status.
Investors holding or tracking this stock should update their records to reflect the new name (Cohance Lifesciences Limited) and new NSE symbol (COHANCE) from May 19, 2025. The BSE scrip code stays the same, so existing holdings and ISINs are unaffected.